Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Exelixis Inc (NASDAQ:EXEL)

12.79
Delayed Data
As of 4:00pm ET
 +0.51 / +4.15%
Today’s Change
3.55
Today|||52-Week Range
15.58
+126.77%
Year-to-Date
Why Exelixis, Inc. Continued Its Downfall Today
Sep 29 / MotleyFool.com - Paid Partner Content
Surging Earnings Estimates Signal Good News for Exelixis (EXEL)
Sep 26 / Zacks.com - Paid Partner Content
Why Exelixis, Inc. Got Hammered Today
Sep 28 / MotleyFool.com - Paid Partner Content
3 Reasons Momentum Stock Investors Will Love Exelixis (EXEL)
Sep 20 / Zacks.com - Paid Partner Content
Exelixis (EXEL) Stock Plummets on Cancer Drug Trial Results, Leerink: Selloff Overdon...
Sep 28 / TheStreet.com - Paid Partner Content
These 3 Stocks Have Doubled Their Investors' Money
Sep 17 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close12.28
Today’s open12.44
Day’s range12.13 - 12.99
Volume9,288,248
Average volume (3 months)6,462,498
Market cap$2.8B
Dividend yield--
Data as of 4:00pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)+41.30%
Earnings growth (this year)+23.25%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+48.03%
P/E ratioNM
Price/Sales31.75
Price/Book--

Competitors

 Today’s
change
Today’s
% change
INCRINC Research Holding...+0.39+0.88%
PRAHPRA Health Sciences ...+1.24+2.24%
PRXLPAREXEL Internationa...+0.95+1.39%
CRLCharles River Labora...+0.80+0.97%
Data as of 4:01pm ET, 09/30/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$37.2M
Annual profit (last year)-$169.7M
Net profit margin-456.63%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer &
Executive Vice President
Christopher J. Senner
Corporate headquarters
South San Francisco, California

Forecasts

Search for Jobs